Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Clinical Nuclear Medicine|September 3, 2021
Cholesterol Granuloma: Unusual Pitfall for Hodgkin Lymphoma Evaluation With 18F-FDG PET/CTHaifa Bahri, Catherine Chassagne-Clement, Anne-Sophie Michallet, et al.Endocrine Pathology|July 13, 2002
Pancreatic Neuroendocrine Carcinoma Metastatic to the Breast as Part of the Multiple Endocrine Neoplasia Type 1 SyndromeIsabelle Treilleux, Gilles Freyer, Eric Tabone, et al.Virchows Archiv : an International Journal of Pathology|November 20, 2023
T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literatureJérémy Schoelinck, Julie Gervasoni, Yann Guillermin, et al.Presse Medicale (Paris, France : 1983)|March 9, 2016
[Histiocytoses: General classification and molecular criteria]Jean-François Emile, Frédéric Charlotte, Catherine Chassagne-Clement, et al.Hematological Oncology|August 14, 2012
Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patientsHervé Ghesquières, Youenn Drouet, Marie Pierre Sunyach, et al.Leukemia|June 21, 2024
First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphomaVincent Cabaud Gibouin, Manon Durand, Christophe Boudesco, et al.Genes, Chromosomes & Cancer|December 23, 2018
Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphomaIdoia Martin-Guerrero, Itziar Salaverria, Birgit Burkhardt, et al.Cancer Chemotherapy and Pharmacology|December 5, 2009
Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trialDelphine Rolland, Vincent Ribrag, Corinne Haioun, et al.Blood|June 7, 2018
HSP110 sustains chronic NF-κB signaling in activated B-cell diffuse large B-cell lymphoma through MyD88 stabilizationChristophe Boudesco, Els Verhoeyen, Laurent Martin, et al.Hemasphere|September 13, 2021
Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and NOTCH1/FBXW7 StatusAmélie Trinquand, Adriana Plesa, Chrystelle Abdo, et al.Pageof 2